×
Neuronetics Total Liabilities 2017-2025 | STIM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Neuronetics total liabilities from 2017 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Neuronetics Total Liabilities 2017-2025 | STIM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Neuronetics total liabilities from 2017 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$186.1B
Intuitive Surgical (ISRG)
$169.7B
IDEXX Laboratories (IDXX)
$51.8B
Edwards Lifesciences (EW)
$47.8B
Alcon (ALC)
$39.4B
IQVIA Holdings (IQV)
$32.4B
DexCom (DXCM)
$29.5B
Mettler-Toledo (MTD)
$26.8B
STERIS (STE)
$24.1B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.4B
Hologic (HOLX)
$14.9B
Penumbra (PEN)
$10.6B
Globus Medical (GMED)
$8.3B
Sysmex ADR (SSMXY)
$7.9B
Masimo (MASI)
$7.6B
Teleflex (TFX)
$5.6B
Glaukos (GKOS)
$5.5B
TransMedics (TMDX)
$3.9B
Integer Holdings (ITGR)
$3.8B
LivaNova (LIVN)
$3.1B
Veracyte (VCYT)
$2.4B
Alphatec Holdings (ATEC)
$2.4B
PROCEPT BioRobotics (PRCT)
$2.2B
Artivion (AORT)
$2.1B
Nihon Kohden (NHNKY)
$2B
Elekta AB (EKTAY)
$1.8B
Integra LifeSciences Holdings (IART)
$1.2B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B